Support through mobile messaging and digital health technology for diabetes

Not Applicable

Completed

• Conditions: Type 2 diabetes mellitus; Nutritional, Metabolic, Endocrine

• Registration Number: ISRCTN13404264
• Lead Sponsor: niversity of Oxford

Brief Summary

2021 Other publications in https://pubmed.ncbi.nlm.nih.gov/33769299/ describes the SMS-based system developed for and evaluated in SuMMiT-D (added 29/03/2021) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35486430/ influence on psychological constructs that predict adherence (added 03/05/2022) 2019 Protocol article in http://dx.doi.org/10.1136/bmjopen-2019-033504 (added 17/11/2023) 2024 Results article in https://pubmed.ncbi.nlm.nih.gov/38273420/ feasibility results (added 30/01/2024)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-10-10
• Study Completion: 2021-08-31
• Last Update Posted: 12 February 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 209

Inclusion Criteria

Current participant inclusion criteria as of 04/01/2019:
COHORT 1 (people with diabetes):
1. Participant is willing and able to give informed consent for participation in the trial
2. Male or female, =35 years of age
3. Type 2 diabetes
4. Taking oral glucose lowering treatment, blood pressure lowering treatment or lipid lowering treatment either alone or in combination
5. Has access to a mobile phone and is able, if necessary with help (e.g. relative, friend, neighbour), to send, understand and retrieve brief SMS text-messages in the English language
6. The participant's practice is taking part in the trial

COHORT 2 (health care professionals):
Any health care professionals (including doctors, nurses, receptionists, practices managers and pharmacists) involved in the care of patients recruited to the trial.

Previous participant inclusion criteria:
COHORT 1 (people with diabetes):
1. Participant is willing and able to give informed consent for participation in the trial
2. Male or female, =35 years of age
3. Type 2 diabetes
4. Taking oral glucose lowering treatment, blood pressure lowering treatment or lipid lowering treatment either alone or in combination
5. Has started one or more of these medications or had a change in one of these medications within the last three months
6. Has access to a mobile phone and is able, if necessary with help (e.g. relative, friend, neighbour), to send, understand and retrieve brief SMS text-messages in the English language
7. The participant's practice is taking part in the trial

COHORT 2 (health care professionals):
Any health care professionals (including doctors, nurses, receptionists, practices managers and pharmacists) involved in the care of patients recruited to the trial.

Exclusion Criteria

COHORT 1 (people with diabetes):
1. Female participant who is pregnant, within three months post-partum or planning pregnancy during the course of the trial
2. A serious medical condition that, in the opinion of the investigator makes them ineligible
3. Insulin treatment without also concomitant use of oral glucose lowering treatment
4. Another person in the household already participates in the trial
5. Patient has been admitted to hospital within the last three months for hyper- or hypoglycaemia (self-report)

COHORT 2 (health care professionals):
No exclusions

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Participant recruitment to trial and willingness to be randomised. Outcome measure: Recruitment against planned recruitment rates. Number of people showing an interest and not proceeding or those who withdraw from the control group and give a reason; Timepoint(s): End of recruitment period